Edupreneur Hub By Dr Gargi Roy Goswami
Eclectica – The Different News Episode 26: Xaliva In Drug and Disease Detection – A portable saliva based point-of-care device Dr. Himanshu Bhatia is a physician-scientist and the founder and CEO of RICOVR Healthcare Inc, USA. Himanshu has an extensive background in clinical medicine as well as basic sciences. Ricovr is a medical device company with a focus on using saliva for rapid point of care testing. Ricovrs’ patented technology is capable of ultrasensitive detection of analytes and biomarkers including bacterial and viral detection.
![National Institute for Health (NIH) National Institute on Drug Abuse Awards Grant to Ricovr Healthcare for Marijuana Device Platform](https://www.ricovr.com/wp-content/uploads/2024/07/web-NIH_NIDA_Vertical_Logo_2Color.jpg)
Blog
Ricovr Healthcare Awarded NIH Grant to Advance Development of Point-of-Care Cannabis Screening Platform
Ricovr Healthcare secures NIH grant to develop XALIVA®, an innovative